Fairvalue-Calculator Fairvalue-Calculator
EN DE

Adia Med Inc (ADIA) Fair Value & Analysis

Financial Services · US · Market cap $14.6M

Price$0.1210
Fair Value$0.0200
Upside-83.5%
Quality95/100
Evidence: Low Range $0.0100 – $0.0200

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Adia Med Inc (ADIA) currently trades at $0.1210, while our model-based Fair Value estimate is $0.0200 — implying the stock looks roughly 83.5% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Adia Med Inc offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

Open the full interactive analysis →

Similar stocks

The Coca-Cola Company (COLA) -61% Lionheart III Corp (LION) -67% Agriculture & Natural Solutions Acquisition Corporation (ANSC) -82% AA Mission Acquisition Corp (AAM) -12% GP-Act III Acquisition Corp (GPAT) -61% Berto Acquisition Corp (TACO) +7%

Frequently asked questions

Is Adia Med Inc (ADIA) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0200 versus a price of $0.1210 — about −83% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ADIA?
Our 21-model fair value for Adia Med Inc is $0.0200 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.1210.
What is the quality score of ADIA?
Adia Med Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.